Exhibit 99.2
SPECIAL MEETING OF TETRAPHASE PHARMACEUTICALS, INC.
Date: | June 8, 2020 | |
Time: | 10:00 a.m. (Eastern Time) | |
Place: | www.proxydocs.com/TTPH |
Please make your marks like this: ☒ Use dark black pencil or pen only
The Board of Directors Recommends a VoteFOR proposals 1, 2 and 3.
For | Against | Abstain | ||||||||
1: | To adopt the Agreement and Plan of Merger, dated as of March 15, 2020 (as it may be amended from time to time), by and among AcelRx Pharmaceuticals, Inc., a Delaware corporation (“AcelRx”), Tetraphase Pharmaceuticals, Inc., a Delaware corporation (“Tetraphase”), and Consolidation Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of AcelRx (“Merger Sub”), pursuant to which Merger Sub will merge with and into Tetraphase, with Tetraphase as the surviving corporation and an indirect wholly-owned subsidiary of AcelRx (the “Merger”). | ☐ | ☐ | ☐ | ||||||
For | Against | Abstain | ||||||||
2: | To approve, on a nonbinding advisory basis, “golden parachute” compensation payments that may be payable to Tetraphase’s named executive officers in connection with the Merger. | ☐ | ☐ | ☐ | ||||||
For | Against | Abstain | ||||||||
3: | To approve the adjournment of the Special Meeting of Tetraphase (the “Special Meeting”) to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal 1 or to ensure that any supplement or amendment to the proxy statement/prospectus is timely provided to Tetraphase stockholders. | ☐ | ☐ | ☐ | ||||||
TO ATTEND the Special Meeting please visit www.proxydocs.com/TTPH to register for the Special Meeting, which is being held virtually. | ||||||||||
Authorized Signatures - This section must be completed for your Instructions to be executed. |
|
| |||||||
Please Sign Here | Please Date Above | |||||||
|
| |||||||
Please Sign Here | Please Date Above | |||||||
Please sign exactly as your name(s) appears on your stock certificate. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy. |
![]() ![]() |
Special Meeting of Tetraphase Pharmaceuticals, Inc.
to be held on June 8, 2020
for Holders as of April 22, 2020
This proxy is being solicited on behalf of the Board of Directors of Tetraphase Pharmaceuticals, Inc.
VOTE BY: | ||||||
![]() | ![]() | |||||
Go To | Call | |||||
www.proxypush.com/TTPH | 866-416-3857 |
• | Cast your vote online. | OR | • | Use any touch-tone telephone. | ||||
• |
Have your Proxy Card/Voting Instructions Form ready. | ![]() | • • | Have your Proxy Card/Voting Instruction Form ready. Follow the simple recorded instructions. | ||||
• | View Meeting Documents. |
OR | • | Mark, sign and date your Proxy Card/Voting Instruction Form. | ||
• | Detach your Proxy Card/Voting Instruction Form. | |||
• | Return your Proxy Card/Voting Instruction Form in the | |||
postage-paid envelope provided. |
The undersigned hereby appoints Larry Edwards and Maria Stahl, and each of them, as the true and lawful attorneys of the undersigned, with full power of substitution and revocation, and authorizes them, and each of them, to vote all the shares of capital stock of Tetraphase Pharmaceuticals, Inc. which the undersigned is entitled to vote at said meeting and any adjournment thereof upon the matters specified and upon such other matters as may be properly brought before the meeting or any adjournment thereof, conferring authority upon such true and lawful attorneys to vote in their discretion on such other matters as may properly come before the meeting and revoking any proxy heretofore given.
THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS GIVEN, SHARES WILL BE VOTED FOR PROPOSAL 1, PROPOSAL 2 AND PROPOSAL 3, AND IN THE DISCRETION OF THE PROXYHOLDERS ON ANY OTHER MATTER THAT PROPERLY COMES BEFORE THE MEETING.
Please vote by 11:59 P.M., Eastern Time, June 7, 2020.
PROXY TABULATOR FOR
TETRAPHASE PHARMACEUTICALS, INC. c/o MEDIANT COMMUNICATIONS | ||||
P.O. BOX 8016 CARY, NC 27512-9903 | ||||
| ||||